Course Description
Infiltrative Cardiomyopathy Symposium– Infiltrative cardiomyopathies, including cardiac amyloidosis and cardiac sarcoidosis, are complex and often underdiagnosed conditions that require early recognition, specialized evaluation, and coordinated, multidisciplinary care. This educational course is designed to address key knowledge gaps among clinicians by providing up-to-date information on diagnostic strategies, pharmacologic therapies, and advanced treatment options, including ICD and pacemaker implantation, LVAD therapy, and heart transplantation. Participants will gain a deeper understanding of how to identify and manage these conditions using a patient-centered and team-based approach.
Through expert-led lectures, real-world case discussions, interactive Q&A sessions, and a keynote address from a recognized leader in the field, this course will offer practical, clinically relevant tools to enhance decision-making and improve outcomes. Attendees will leave better equipped to recognize the signs of infiltrative heart disease, utilize advanced imaging and referral pathways, and implement comprehensive treatment plans in collaboration with subspecialists across cardiology, electrophysiology, imaging, and heart failure care.
Target Audience
- Cardiology healthcare professionals and fellows involved in heart failure management
- Nurse practitioners, physician assistants, and allied health professionals
- Specialists in electrophysiology, interventional, imaging, and advanced heart failure cardiology
- Specialists in pulmonary, rheumatology, neurology, radiology, pathology.
- Primary care providers and general cardiologists
Learning Objectives
Upon completion of this activity, learners will be able to:
- Recognize unique conditions in patients with heart disease, including cardiac amyloidosis and cardiac sarcoidosis.
- Identify the appropriate timing for specialized diagnostics and referral to specialists.
- Describe the evaluation process for suspected infiltrative cardiomyopathy.
- Explore the most current treatment modalities for infiltrative cardiomyopathies, including pharmacologic options, advanced heart failure therapies, and interventional therapies.
- Understand the selection criteria for ICD and pacemaker implantation.
Registration
Registration for Infiltrative Cardiomyopathy Symposium
Click the register button to visit our secure website for updated program and registration information. We are unable to accept registrations or cancellations by telephone.
If you are a fellow in-training, please email a letter of good standing from your program director to info@infiltrativecardio.org for a complimentary registration code.
Cancellation Policy
Cancellations made in writing by October 31, 2025, will be subject to a 50% penalty. No refunds will be given starting November 1, 2025. Cancellations will not be accepted by telephone. In the unlikely event that the course is cancelled, we will refund the registration fee, but are not responsible for any travel costs.
Please contact us at info@infiltrativecardio.org if you have questions or need additional information.
Event Schedule
NOTE: This is a draft agenda and subject to change
Saturday, December 6, 2025
7:30 AM
Registration and Breakfast
8:00 AM
Welcoming and Introduction
Nisha A. Gilotra, MD, and Farooq H. Sheikh, MD
Session I | How to Identify and Diagnose an Infiltrative Cardiomyopathy
8:05 AM
Lay of the Land: When to Suspect Infiltrative Heart Diseases
Nana Afari-Armah, MD
8:25 AM
Clinical Manifestations and Diagnostic Algorithm: Cardiac Amyloidosis
Stephen S. Gottlieb, MD
8:45 AM
Clinical Manifestations and Diagnostic Algorithm: Cardiac Sarcoidosis
Tania A. Vora, MD
9:05 AM
Panel Discussion
Moderators: Sumeet S. Mitter, MD, MSc, and Tania A. Vora, MD
Panelists: Nana Afari-Armah, MD; and Stephan S. Gottlieb, MD
Keynote Speaker
9:25 AM
Cardiac Amyloidosis 2025: Reflections on Innovation and Advocacy
Mat Maurer, MD
9:55 AM
Cardiac Amyloidosis 2025: Q&A
10:05 AM
Break | Refreshments and Exhibits
Session II | Diagnostic Tools in Infiltrative Cardiomyopathy
10:50 AM
The Role of Echocardiography
Allison G. Hays, MD
11:00 AM
Cardiac MRI in Infiltrative Cardiomyopathies
Stefan L. Zimmerman, MD
11:10 AM
Cardiac Scintigraphy in Cardiac Amyloidosis
Carlos A. Garica, MD
11:20 AM
FDG PET Imaging in Inflammatory Cardiomyopathies
Paco E. Bravo, MD
11:30 AM
Hemos and Histo
Mitch Psotka, MD, PhD
11:40 AM
Incorporation of Genetic Testing in the Diagnostic Evaluation
Brittney Murray, MS, CGC
11:50 AM
Panel Discussion
Moderators: Albert J. Hicks III, MD, MPH, and Ajay Kadakkal, MD
Panelists: Paco E. Bravo, MD; Carlos A. Garcia, MD; Allison G. Hays, MD; Brittney Murray, MS, CGC; Mitch Psotka, MD, PhD; and Stefan L. Zimmerman, MD
Lunch and Networking
12:05 PM
Lunch
12:20 PM
Lunch Presentation
Location: Chesapeake B
Speaker
1:05 PM
Break | Dessert and Networking
Saturday, December 6, 2025
Session III | Therapeutic Landscape for Infiltrative Cardiomyopathies
1:20 PM
Treatment in Transthyretin Cardiac Amyloidosis (ATTR-CM)
Joban Vaishnav, MD
1:40 PM
Treatment for AL Amyloidosis
Ajay Kadakkal, MD
2:00 PM
Immunosuppression for Cardiac Sarcoidosis
Sumeet S. Mitter, MD, MSc
2:20 PM
Panel Discussion
Moderators: Matt Maurer, MD, and Farooq H. Sheikh, MD
Panelists: Ajay Kadakkal, MD; Sumeet S. Mitter, MD, MSc; and Joban Vaishnav, MD
Session IV | It Takes a Village: Team-Based Care for Infiltrative Cardiomyopathies
2:40 PM
Assessing and Managing Neuro-Autonomic Manifestations of Amyloidosis
Michael J. Polydefkis, MD
2:50 PM
Assessing and Managing Extracardiac Manifestations of Sarcoidosis
Michelle Sharp, MD, MHS
3:00 PM
Special Considerations for Heart Failure Management
Gurusher Panjrath, MD
3:10 PM
The Role of Interventional Cardiology (Diagnosis and Treatments)
Lowell Satler, MD
3:20 PM
Controversies in Electrophysiology
Jonathan Chrispin, MD
3:30 PM
The Role of Supportive Care in Infiltrative Heart Disease
Anirudh Rao, MD
3:40 PM
Panel Discussion
Moderators: Nisha A. Gilotra, MD, and Joban Vaishnav, MD
Panelists: Jonathan Chrispin, MD; Gurusher Panjrath, MD; Michael J. Polydefkis, MD; Anirudh Rao, MD; Lowell Satler, MD; and Michelle Sharp, MD, MHS
3:55 PM
Closing Remarks
Nisha A. Gilotra, MD, and Farooq H. Sheikh, MD
4:00 PM
Adjourn
Faculty
Course Directors
Nisha A. Gilotra, MD
Johns Hopkins Medicine
Baltimore, MD
Farooq H. Sheikh, MD
MedStar Health
Washington, DC
Nana Afari-Armah, MD
MedStar Health
Washington, DC
Paco E. Bravo, MD
University of Pennsylvania
Philadelphia, PA
Jonathan Chrispin, MD
Johns Hopkins Medicine
Baltimore, MD
Carlos A. Garcia, MD
MedStar Health
Washington, DC
Stephen S. Gottlieb, MD
University of Maryland
Baltimore, MD
Allison G. Hays, MD
Johns Hopkins Medicine
Baltimore, MD
Albert J. Hicks III, MD, MPH
University of Maryland
Baltimore, MD
Ajay Kadakkal, MD
MedStar Health
Washington, DC
Matt Maurer, MD
Columbia University
New York, NY
Sumeet S. Mitter, MD, MSc
Inova
Falls Church, VA
Brittney Murray, MS, CGC
Johns Hopkins Medicine
Baltimore, MD
Gurusher Panjrath, MD
George Washington University
Washington, DC
Michael J. Polydefkis, MD
Johns Hopkins Medicine
Baltimore, MD
Mitchell Psotka MD, PhD
Inova
Falls Church, VA
Anirudh Rao, MD
Inova
Falls Church, VA
Lowell Satler, MD
MedStar Health
Washington, DC
Michelle Sharp, MD, MHS
Johns Hopkins Medicine
Balitmore, MD
Joban Vaishnav, MD
Johns Hopkins Medicine
Baltimore, MD
Tania A. Vora, MD
MedStar Health
Washington, DC
Stefan L. Zimmerman, MD
Johns Hopkins Medicine
Balitmore, MD
CME Accreditation
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation
The Academy for Continued Healthcare Learning designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician assistants, nurse practitioners, and nurses may participate in this educational activity and earn a certificate of completion as AAPA, AANP, and ANCC accept AMA PRA Category 1 Credits™ through their reciprocity agreements.
Disclaimer
Guidelines require that learners in CME activities be made aware of all relevant financial relationships affecting the presentation of the faculty member. ACHL ensures that all faculty and staff involved in the planning, development, and implementation of ACHL activities disclose financial relationships held within 24 months and that relevant financial relationships are mitigated before a CME activity occurs. Complete information will be provided to learners prior to the start of the educational activity.
Exhibitors
Infiltrative Cardiomyopathy Symposium is a one-day program designed to provide a venue for attendees to review infiltrative heart diseases, such as cardiac amyloidosis and cardiac sarcoidosis, pose unique diagnostic and therapeutic challenges. Due to their rarity and complexity, healthcare providers may lack familiarity with optimal strategies for early recognition, specialized evaluation, and multidisciplinary care. These conditions require timely referral and coordinated treatment approaches, including advanced pharmacologic therapies, multi-organ management, cardiac surgical interventions like LVAD implantation and heart transplantation, as well as appropriate use of implantable cardioverter defibrillators (ICDs) and pacemakers.
